Aisling Capital Management LP
Annual return '25
+14.7%
SPY '25
+17.7%
Alpha
-3.0ptsvs SPY
Invested
$476.3M
Holdings
13
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 100%. 3 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$BBIO
BridgeBio Pharma Inc. (BBIO)
Q1 2026: Exited (was 5.09M shares)
79.4%
02
$SNDX
Syndax Pharmaceuticals, Inc. (SNDX)
Q1 2026: Exited (was 1.32M shares)
6.5%
03
$GLUE
Monte Rosa Therapeutics Inc (GLUE)
Q1 2026: Exited (was 1.47M shares)
5.4%
04
$BCAX
Bicara Therapeutics Inc. (BCAX)
Q1 2026: Exited (was 568.9k shares)
2.4%
05
$BBOT
BridgeBio Oncology Therapeutics (BBOT)
Q1 2026: Exited (was 564.6k shares)
1.9%
06
$CMPS
Compass Pathways Plc (CMPS)
Q1 2026: Exited (was 1.20M shares)
1.7%
07
$SRRK
Scholar Rock Holding Corporation (SRRK)
Q1 2026: Exited (was 77.0k shares)
0.8%
08
$BMEA
Biomea Fusion Inc (BMEA)
Q1 2026: Exited (was 2.05M shares)
0.7%
09
$EPRX
Eupraxia Pharmaceuticals Inc. (EPRX)
Held since at least Q1 2024
0.5%
10
$URGN
Urogen Pharma Ltd. (URGN)
Q1 2026: Exited (was 108.0k shares)
0.4%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 10:39 UTC.